BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 789027)

  • 1. S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction.
    Edwards GF; Steel AE; Scott JK; Jordan JW
    Chest; 1976 Oct; 70(4):506-13. PubMed ID: 789027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung.
    Thomson ML; Pavia D; Jones CJ; McQuiston TA
    Thorax; 1975 Dec; 30(6):669-73. PubMed ID: 769242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in sputum in catarrhal bronchitis in children after treatment with S-carboxymethylcysteine (viscosimetric studies)].
    Castello D; Costa G; De Candussio G
    Minerva Pediatr; 1979 Mar; 31(5):371-80. PubMed ID: 460097
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of S-carboxymethylcysteine on the biophysical and biochemical properties of mucus in chronic bronchitics.
    Cox A; Jabbal-Gill I; Marriott C; Davis SS
    Adv Exp Med Biol; 1982; 144():423-9. PubMed ID: 7080939
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of S-carboxymethylcysteine on tracheal mucus velocity.
    Goodman RM; Yergin BM; Sackner MA
    Chest; 1978 Dec; 74(6):615-8. PubMed ID: 367726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the mucoregulator S-carboxy-methyl-cysteine in patients with chronic bronchitis.
    Puchelle E; Aug F; Polu JM
    Eur J Clin Pharmacol; 1978 Nov; 14(3):177-84. PubMed ID: 365537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies of the clinical effectiveness of the mucolytic drug, S-carboxymethylcysteine, in the therapy of acute and chronic bronchitis].
    Magliulo E; Bonizzoni D; Cattaneo E; Scevola D; Concia E
    Minerva Med; 1975 Apr; 66(25):1187-97. PubMed ID: 1134660
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment.
    Braga PC; Bossi R; Allegra L
    Int J Clin Pharmacol Res; 1984; 4(2):121-7. PubMed ID: 6469438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic behavior of S-carboxymethylcysteine-Lys in patients with chronic bronchitis.
    Braga PC; Borsa M; De Angelis L; Bossi R; Allegra L; Scaglione F; Scarpazza G
    Clin Ther; 1982; 4(6):480-8. PubMed ID: 7093981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimal use of expectorants (current trends)].
    Mirrakhimov MM; Brimkulov NN; Rafibekova ZhS
    Ter Arkh; 1981; 53(1):110-7. PubMed ID: 7013137
    [No Abstract]   [Full Text] [Related]  

  • 11. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis.
    Aylward M
    Curr Med Res Opin; 1973; 1(4):219-27. PubMed ID: 4589629
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
    Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB
    Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term oral carbocisteine therapy in patients with chronic bronchitis. A double blind trial with placebo control.
    Grillage M; Barnard-Jones K
    Br J Clin Pract; 1985 Oct; 39(10):395-8. PubMed ID: 3907681
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical therapeutic evaluation of methylcysteine hydrochloride in patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control.
    Aylward M; Bater PA; Davies DE; Hutchings LA; Lewis PA; Maddock J; Protheroe DA
    Curr Med Res Opin; 1978; 5(6):461-71. PubMed ID: 350498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study.
    Jackson IM; Barnes J; Cooksey P
    J Int Med Res; 1984; 12(3):198-206. PubMed ID: 6376210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo.
    Olivieri D; Zavattini G; Tomasini G; Daniotti S; Bonsignore G; Ferrara G; Carnimeo N; Chianese R; Catena E; Marcatili S
    Respiration; 1987; 51 Suppl 1():42-51. PubMed ID: 3299567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-carboxymethylcysteine in the treatment of glue ear: a double blind trial.
    Ramsden RT; Moffat DA; Gibson WP; Jay MM
    J Laryngol Otol; 1977 Oct; 91(10):847-51. PubMed ID: 336818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucodine in the treatment of chronic bronchitis].
    Wierzbicka M; Wójcik RA
    Pneumonol Pol; 1981; 49(5):369-76. PubMed ID: 7022385
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis.
    Tamaoki J; Chiyotani A; Tagaya E; Sakai N; Konno K
    Thorax; 1994 Jun; 49(6):545-8. PubMed ID: 8016790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
    Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
    Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.